Clinical Trials List
2021-04-20 - 2024-07-02
Phase III
Recruiting7
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 黃偉銘 Division of Cardiovascular Diseases
- 李慶威
- Chern-En Chiang Division of Cardiovascular Diseases
- 吳承學 Division of General Internal Medicine
- 張俊欽 Division of Cardiovascular Diseases
- 陳俊谷 Division of Radiation Therapy
- Wen-Chung Yu Division of Cardiovascular Diseases
- Hao-min Cheng 教學部
- Chin-Sung Kuo Division of Endocrinology
- Tse-Min Lu Division of Family Medicine
- 黃少嵩 Division of Family Medicine
- 游偉光 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
70 participants
-
Global
700 participants
